In this episode of Brains Byte Back, we explore the future of neurotechnology with a special guest, Israel Gasperin, founder and CEO of Zentrela. Israel's company is leading the charge in using artificial intelligence (AI) to analyze brainwaves, developing groundbreaking tools that measure cognitive impairment in ways traditional drug tests can’t.
In 2018, the historic legalization of cannabis in Canada is where Zentrela really took off. With government funding and support in his research, he was able to create cutting-edge tools for effectively measuring cannabis impairment. Today, Zentrela's AI-based EEG technology is being used globally to help a variety of industries, including cannabis, energy drinks, and wellness, conduct faster, more cost-effective product testing – giving consumers direct insight into the psychoactive and non-psychoactive effects of the products they are buying.
They are essentially providing companies and consumers with a new kind of label—not the traditional listing of ingredients but rather the effects of the product. The future of brainwave analysis is shaping the way companies research, develop, and inform their customers like never before—Israel shares how.
Find out more about Israel Gasperin here (Linkedin) -
https://www.linkedin.com/in/israelgasperin/
Find out more about Zentrela (website) -
https://zentrela.com/
Brains Byte Back:
Reach out to today's host, Erick Espinosa (Linkedin) -
linkedin.com/in/erick-espinosa
Get the latest on tech news - https://sociable.co/
Leave an iTunes review - https://rb.gy/ampk26
Follow us on your favourite podcast platform - https://link.chtbl.com/rN3x4ecY
Find out more about our sponsor Publicize -https://publicize.co/startup-resources/
